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Case Report
Orbital Metastatic Angiosarcoma
Souhail Hassane, Elasri Fouad, Iferkhass Said, Reda Karim, Naoumi Asmae, 
Chana Houcine, Oubaaz Abdelbar
Department of Ophthalmology, Mohammed V Military Teaching Hospital, University of King Mohammed V-Souissi, Rabat, Morocco
We report a case of a 48-year-old man who developed metastatic angiosarcoma in her left orbit. A 48-year-old man 
was first sent to us for a check up of proptosis of the left eye. A left orbital tumor was recognized on orbital computed 
tomography scans. The open biopsy showed angiosarcoma. Chest X-ray films and thoracic computed tomography 
showed an abnormal mass in the left inferior lung field. Angiosarcoma was confirmed by transbronchial lung biopsy. 
In summary, we believed that the orbital tumour was an initial symptom of the metastasis ensuing from the lung 
angiosarcoma.
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The first descriptions of orbital and ocular metastases were 
made by Horner in 1864 and Perle in 1872 [1,2]. These meta-
stases constitute 0, 5-5, 0% of all orbital tumours [3]. For the 
majority sites responsible for these metastases, they are car-
cinoma, the breast and the lung are the first primary sites re-
sponsible for these metastases (breast carcinoma in woman 
and lung or digestive cancer in man), however, metastatic or-
bital tumors presenting as the first sign of disseminate cancer 
are a rare event [1-3]. Angiosarcomas comprise 1% of all soft 
tissue sarcomas, with an orbital incidence of 3% of those 
cases. The majority is primary angiosarcoma; only two pre-
vious case of metastatic angiosarcoma to the orbit has been 
described [2]. Treatment options and efficacy is not well 
understood.
Case Report
A 48-year-old man smoking for 30 years was due to a pack 
a day presented a one-month history of exophthalmia, che-
mosis (Fig. 1) and diplopia. An ophthalmic examination 
shows a visual acuity as 20/20 in OD, and in 15/20 OS check 
pupils is normal and exophthalmometry shows 6 mm propto-
sis in OS. Motility examination on admission demonstrated a 
left oculomotor limitation in all direction, accompanied with 
pain and a ledger left ptosis. The fundus examination was 
normal. A neurological examination on admission demon-
strated a left oculomotor palsy, accompanied with pain. 
Computed tomography (CT) showed a left superior orbital 
mass causing bone destruction, was extended to brain (Fig. 
2), the radiologist suspected a metastasis with unknown pri-
mary site. Therefore, a more thorough systemic evaluation 
was started to detect primary malignancy. The immunohisto-
logic staining of the incisional biopsy specimen showed an-
giosarcoma, the tumor cells were positive for factor VIII and 
CD31 (Figs. 3-5). The biopsy was complicated by in-
flammatory edema of the orbit (Fig. 6). A chest X-ray film 
completed by thoracic CT has shown an abnormal mass in 
the left posterior and inferior lung field (Fig. 7). Angiosar- S Hassane, et al. Orbital Metastatic Angiosarcoma
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Fig. 5. Tumoral cells are staining by factor VIII.
Fig. 6. Tumoral cells are marking with CD31 factor.
Fig. 7. Important leap of inflammatory oedema of the orbit after biopsy.
Fig. 2. Coronal computed tomography shows a superior orbital 
mass with bony destruction and brain extended.
Fig. 3. Chest computed tomography showing a left lung tumor.
Fig. 4. Orbital metastasis of bronchial angiosarcoma (H&E, ×200).
coma has been diagnosed by transbronchial lung biopsy in 
immunohistological study (Fig. 8). The left orbital tumor was 
thought to be a metastasis caused by the lung cancer.
The patient received radiation therapy for the metastatic 
orbital tumor with a total dose 2,000 cGy in 10 fractions of 
200 cGy per fraction and chemotherapy (cisp1atin 100 
mg/m2 IV; day 1 + etoposide 100 mg/m2; days 1-3 repeated 
every 4 weeks for 2 months) for the lung cancer. However, he 
died 3 months after initial treatment because of the pro-
gression of the primary lesion as Weil as the progressive sys-Korean J Ophthalmol Vol.24, No.6, 2010
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Fig. 8. Bronchial mucosa showed lumina lined by sarcomatous cells
(H&E, ×200).
temic metastasis in the brain.
Discussion
Angiosarcomas are malignant neoplasms derived from en-
dothelial cells of arteries, or veins. The origin of these tumors 
is unknown. The metastatic orbital angiosarcomas is excep-
tional, we believe this is the third reported case of metastatic 
angiosarcoma to the orbit [1,2].
The confirmation is done by histopathologic evaluation, 
when cytokeratin is negative or focally positive with vi-
mentin reactivity, a vascular tumor should be suspected and 
confirmed with vascular markers, CD31, CD34, and factor 
VIII [3]. These are the endothelial-specific immunologic 
markers with variable specificity and sensitivity. Factor 
VIII-related antigen, in spite of its high specificity, is be-
lieved to be relatively insensitive, particularly in malignant 
vascular tumors. CD34 was reported to be a specific and sen-
sitive endothelial marker, but it also reacts with nonvascular 
soft tissue neoplasm, including epitheloid sarcoma, malig-
nant peripheral nerve sheath tumor, leiomyosarcoma, and 
clear cell sarcoma. CD31 has been shown to be a highly spe-
cific and sensitive endothelial marker that reacts rarely and 
only weakly with nonvascular tumours [3].
The optimal therapy for angiosarcoma is not established. 
Resection, radiation, or combined resection and radiation 
were used in treating the angiosarcoma of the cranium, com-
plete surgical resection in other sites followed by radiation 
therapy results better in long-term control of disease thane 
surgery alone. There may be reduction in recurrence with ad-
juvant chemotherapy, although the most active agents are not 
known [1]. Paclitaxel appears to be highly specific in dermal 
angiosarcoma, but is palliative [4]. Chemotherapy may be a 
useful adjunct to surgery and/or radiation therapy in the 
management of angiosarcoma; however, chemotherapy 
alone is unlikely to be curative [1]. Nevertheless, we believe 
that angiosarcoma of the orbit may have a worse prognosis 
than angisarcoma of bones other than the cranium, because 
the tumour may secondarily involve the brain and the patient 
dies with increased intracranial pressure [5], as did our case.
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